I am/have/had
I am looking for
Advanced Filters
Found 2 clinical trials
A Study to Investigate the Efficacy and Safety of Rilzabrutinib in Adult Participants With Graves' Disease
This is a parallel group, Phase 2, 2-arm study to measure the treatment effect and safety of rilzabrutinib dose 1 or rilzabrutinib dose 2 in participants with Graves' disease, with and without Graves' orbitopathy, aged 18 years or older.Study details include:Screening period (up to 4 weeks).
- 0 views
- 14 May, 2026
Change of Gut Microbiome in the Treatment of Graves' Disease
Graves' disease is the main cause of hyperthyroidism. Graves' disease has a prevalence of 0.5% in the general population. As a non-surgical treatment, antithyroid drug (ATD) and radioactive iodine treatment have been proposed and ATD is the first-line treatment in Korea.
hyperthyroidism
graves' disease
remission
antithyroid drugs
- 0 views
- 19 Feb, 2024
- 1 location